These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25660152)

  • 1. Treatment of in-stent restenosis with bioresorbable vascular scaffolds: optical coherence tomography insights.
    Rivero F; Bastante T; Cuesta J; Benedicto A; Restrepo JA; Alfonso F
    Can J Cardiol; 2015 Mar; 31(3):255-9. PubMed ID: 25660152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres.
    Fabris E; Caiazzo G; Kilic ID; Serdoz R; Secco GG; Sinagra G; Lee R; Foin N; Di Mario C
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):839-46. PubMed ID: 26370357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
    Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
    JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Bioresorbable Vascular Scaffold Experience Compared With Second-Generation Metallic Drug-Eluting Stents in Complex Coronary Lesions.
    Okamoto N; Ueda H; Yoshimura T; Chamaria S; Bhatheja S; Vengrenyuk Y; Rabiei S; Barrientos Y; Kapur V; Barman N; Sweeny J; Baber U; Mehran R; Sharma SK; Kini AS
    J Invasive Cardiol; 2018 Jul; 30(7):251-255. PubMed ID: 29656280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of in-stent restenosis with sirolimus-eluting magnesium bioresorbable scaffolds: optical coherence tomography insights.
    Cuesta J; Rivero F; Bastante T; Antuña P; Jiménez-Méndez C; García-Guimaraes M; Alfonso F
    Coron Artery Dis; 2022 Aug; 33(5):362-367. PubMed ID: 35170552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-human description of everolimus-eluting bioabsorbable vascular scaffold implantation for the treatment of drug-eluting stent failure: insights from optical coherence tomography.
    Grasso C; Attizzani GF; Patané M; Ohno Y; Capodanno D; Tamburino C
    Int J Cardiol; 2013 Oct; 168(4):4490-1. PubMed ID: 23890924
    [No Abstract]   [Full Text] [Related]  

  • 8. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicenter Italian experience.
    Moscarella E; Varricchio A; Stabile E; Latib A; Ielasi A; Tespili M; Cortese B; Calabrò P; Granata F; Panoulas VF; Franzone A; Trimarco B; Bonzani G; Esposito G; Colombo A
    Int J Cardiol; 2015 Nov; 199():366-72. PubMed ID: 26241643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis.
    Alfonso F; Dutary J; Paulo M; Gonzalo N; Pérez-Vizcayno MJ; Jiménez-Quevedo P; Escaned J; Bañuelos C; Hernández R; Macaya C
    Heart; 2012 Aug; 98(16):1213-20. PubMed ID: 22826559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study.
    Diletti R; Karanasos A; Muramatsu T; Nakatani S; Van Mieghem NM; Onuma Y; Nauta ST; Ishibashi Y; Lenzen MJ; Ligthart J; Schultz C; Regar E; de Jaegere PP; Serruys PW; Zijlstra F; van Geuns RJ
    Eur Heart J; 2014 Mar; 35(12):777-86. PubMed ID: 24394380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience.
    Karanasos A; Van Mieghem N; van Ditzhuijzen N; Felix C; Daemen J; Autar A; Onuma Y; Kurata M; Diletti R; Valgimigli M; Kauer F; van Beusekom H; de Jaegere P; Zijlstra F; van Geuns RJ; Regar E
    Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25969547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation.
    Radu MD; Räber L; Heo J; Gogas BD; Jørgensen E; Kelbæk H; Muramatsu T; Farooq V; Helqvist S; Garcia-Garcia HM; Windecker S; Saunamäki K; Serruys PW
    EuroIntervention; 2014 Jan; 9(9):1085-94. PubMed ID: 24064426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of optical coherence tomography (OCT) in the optimisation of Absorb bioresorbable vascular scaffold deployment during percutaneous coronary intervention.
    Allahwala UK; Cockburn JA; Shaw E; Figtree GA; Hansen PS; Bhindi R
    EuroIntervention; 2015 Feb; 10(10):1154-9. PubMed ID: 24647105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.
    Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-coated balloon for recurrent in-stent restenosis treatment: A suitable strategy.
    Piraino D; Buccheri D; Cimino G; Andolina G
    Int J Cardiol; 2016 Oct; 221():1084-6. PubMed ID: 27448537
    [No Abstract]   [Full Text] [Related]  

  • 17. First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
    Latini RA; Buccheri D; Cortese B
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):676-678. PubMed ID: 27649683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds.
    Caiazzo G; Longo G; Giavarini A; Kilic ID; Fabris E; Serdoz R; Mattesini A; Foin N; Secco GG; De Rosa S; Indolfi C; Di Mario C
    Int J Cardiol; 2016 Oct; 221():352-8. PubMed ID: 27404705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial.
    Nakatani S; Onuma Y; Ishibashi Y; Muramatsu T; Iqbal J; Zhang YJ; van Geuns RJ; Ormiston JA; Serruys PW
    EuroIntervention; 2015 Mar; 10(11):1288-98. PubMed ID: 24572936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Absorb Limits.
    Gómez Menchero AE; Camacho Freire SJ; Díaz Fernández JF; Roa Garrido J; León Jiménez J; Cardenal Piris R
    J Invasive Cardiol; 2016 Oct; 28(10):E122-E123. PubMed ID: 27705895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.